Relapse Prevention Study in Newly Abstinent Smokers

• Status: Withdrawn
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the effect of GSK598809 as compared to placebo in preventing recently-quit smokers from going back to smoking.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• has smoked at least 10 cigarettes a day for at least 2 years

• has had multiple previous attempts to quit smoking and relapsed to smoking.

• generally healthy

Exclusion Criteria:

• cannot be using smokeless tobacco of any type or has tried to quit with medicine.

• does not abuse alcohol or drugs

• certain emotional problems being treated with medications

• pregnant or breast feeding female